MESTINON

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MESTINON contains one active pharmaceutical ingredient (API):

1 Pyridostigmine UNII KVI301NA53 - PYRIDOSTIGMINE BROMIDE

Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine. Read about Pyridostigmine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MESTINON Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07AA02	Pyridostigmine	N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1959D, 2608G, 2724J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541718030017817
Country: CA	Health Products and Food Branch	Identifier(s): 00869953, 00869961
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4865-MEE-1119, 4870-MEE-1119
Country: EE	Ravimiamet	Identifier(s): 1480564, 1664625, 1664647
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 23524
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 173898, 173948
Country: FR	Base de données publique des médicaments	Identifier(s): 67013510, 68333755
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 185923, 199693, 24834, 373649
Country: HK	Department of Health Drug Office	Identifier(s): 03376, 03386, 58081
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-198605655
Country: IE	Health Products Regulatory Authority	Identifier(s): 33855, 36700
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 334
Country: JP	医薬品医療機器総合機構	Identifier(s): 1239003F1046
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004557
Country: MT	Medicines Authority	Identifier(s): MA1507/01401, PI565/78601A, PI729/27301A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 44564, 530M2002
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 6203, 6211
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10009
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100116797, 100442189
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68713001, W68713002, W68713003
Country: SG	Health Sciences Authority	Identifier(s): 02898P, 03214P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698856120021
Country: US	FDA, National Drug Code	Identifier(s): 0187-3010, 0187-3012, 0187-3013
Country: ZA	Health Products Regulatory Authority	Identifier(s): C/5.3/610, UX/5.3/179